Core B: Administrative Core
核心 B:行政核心
基本信息
- 批准号:10606564
- 负责人:
- 金额:$ 10.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-08 至 2027-03-31
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAnnual ReportsBioinformaticsBudgetsCancer CenterCellsCommunicationCommunitiesDataEnsureEthicsEvaluationExperimental DesignsFeedbackFundingGoalsHematologic NeoplasmsHematopoiesisHumanHuman ResourcesInstitutionInstitutional Review BoardsLeadershipMalignant - descriptorManuscriptsMedicineMonitorMusParticipantPatientsProductivityProgram EvaluationProgram ReviewsProtocols documentationPublic Health SchoolsPublicationsRecommendationReportingReproducibilityResearchResearch PersonnelRiceRunningSuggestionTexasTrainingUniversitiesVideoconferencingWorkcohesioncollegegood laboratory practicehigh standardimprovedmeetingsmembermultidisciplinaryprogramssoundstressor
项目摘要
Project Summary
This Program brings together a multidisciplinary team from Baylor College of Medicine, MD Anderson Cancer
Center, Johns Hopkins Bloomberg School of Public Health, Texas A&M University, and Rice University to
examine factors influencing the progression of clonal hematopoiesis to hematologic malignancy in mice and
humans. To facilitate this bold undertaking, Core B (the Administrative Core) will coordinate the activities of the
Program. This Core will (1) facilitate communication within and outside the Program by organizing monthly
scientific meetings including all Program participants and quarterly meetings of Program leadership. The Core
will facilitate an annual meeting including all participants and internal and external advisory board members to
discuss progress and generate feedback. In addition, the Core will ensure that work is communicated to the
scientific community in a timely fashion through presentations, publications, and data release. (2) The Core will
be responsible for sound fiscal management including budgeting and distribution of funds. (3) The Core will
coordinate ongoing evaluation of the Program through internal and external advisory boards and will use the
advisory feedback to adjust the Program plans as needed. (4) The Core will be responsible for ensuring
compliance with ethical considerations with regard to animal and IRB protocol approvals and good laboratory
practices. The Core will ensure that all participating investigators have appropriate and current ethics training.
The Core will also oversee research rigor by ensuring training of all Program personnel and rigorous review.
This Core will also be responsible for statistical evaluation of plans in the Projects. Overall, Core B will facilitate
the highest level of productivity throughout the Program, allowing each Project and Core to work together to
achieve our overall goal of understanding how modifiable stressors cause expansion and malignant
transformation in patients with clonal hematopoiesis.
项目摘要
该计划汇集了来自马里兰州贝勒医学院安德森癌症的多学科团队
中心、约翰霍普金斯布隆伯格公共卫生学院、德克萨斯A & M大学和赖斯大学,
检查影响小鼠中克隆造血向血液恶性肿瘤进展的因素,
人类为推动这项大胆的工作,核心B(行政核心)将协调
程序.该核心将(1)通过每月组织一次
科学会议,包括所有计划参与者和计划领导的季度会议。核心
将促成一次包括所有与会者和内部及外部咨询委员会成员的年度会议,
讨论进展并生成反馈。此外,核心将确保将工作传达给
通过演讲、出版物和数据发布,及时向科学界提供信息。(2)芯会
负责健全的财务管理,包括预算和资金分配。(3)芯会
通过内部和外部咨询委员会协调正在进行的计划评估,并将利用
咨询反馈,以根据需要调整计划。(4)核心将负责确保
符合动物和IRB方案批准和药物非临床研究质量管理规范方面的伦理考虑
实践核心委员会将确保所有参与研究的研究者接受适当的最新伦理培训。
核心还将通过确保所有计划人员的培训和严格的审查来监督研究的严格性。
该中心还将负责对项目计划进行统计评估。总体而言,核心B将促进
在整个计划中实现最高水平的生产力,使每个项目和核心能够协同工作,
实现我们的总体目标,了解如何修改压力导致扩张和恶性
克隆性造血患者的转化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARGARET A. GOODELL其他文献
MARGARET A. GOODELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARGARET A. GOODELL', 18)}}的其他基金
Modifiable Drivers of Expansion and Malignant Transformation from Clonal Hematopoiesis
克隆造血扩张和恶性转化的可改变驱动因素
- 批准号:
10606550 - 财政年份:2022
- 资助金额:
$ 10.66万 - 项目类别:
Modifiable Drivers of Expansion and Malignant Transformation from Clonal Hematopoiesis
克隆造血扩张和恶性转化的可改变驱动因素
- 批准号:
10332334 - 财政年份:2022
- 资助金额:
$ 10.66万 - 项目类别:
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
DNMT3A 相关血液恶性肿瘤的小鼠模型
- 批准号:
8926371 - 财政年份:2014
- 资助金额:
$ 10.66万 - 项目类别:
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
DNMT3A 相关血液恶性肿瘤的小鼠模型
- 批准号:
8761773 - 财政年份:2014
- 资助金额:
$ 10.66万 - 项目类别:
DNMT3A in Development of Hematologic Malignancies
DNMT3A 在血液恶性肿瘤发展中的作用
- 批准号:
10474446 - 财政年份:2014
- 资助金额:
$ 10.66万 - 项目类别:
DNMT3A in Development of Hematologic Malignancies
DNMT3A 在血液系统恶性肿瘤发展中的作用
- 批准号:
10689132 - 财政年份:2014
- 资助金额:
$ 10.66万 - 项目类别:
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
DNMT3A 相关血液恶性肿瘤的小鼠模型
- 批准号:
9544059 - 财政年份:2014
- 资助金额:
$ 10.66万 - 项目类别:
DNMT3A in Development of Hematologic Malignancies
DNMT3A 在血液恶性肿瘤发展中的作用
- 批准号:
10241920 - 财政年份:2014
- 资助金额:
$ 10.66万 - 项目类别:
A Mouse Model of DNMT3A-Associated Hematologic Malignancy
DNMT3A 相关血液恶性肿瘤的小鼠模型
- 批准号:
9318474 - 财政年份:2014
- 资助金额:
$ 10.66万 - 项目类别:
相似海外基金
Culture change in international organizations: Exammining corporate annual reports of Japanese and US corporations
国际组织的文化变迁:审视日本和美国企业的年度报告
- 批准号:
20K01874 - 财政年份:2020
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the value of textual information in annual reports through natural language processing
通过自然语言处理分析年报文本信息的价值
- 批准号:
18K18566 - 财政年份:2018
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysing Narrative Aspects of UK Preliminary Earnings Announcements and Annual Reports: Tools and Insights for Researchers and Regulators
分析英国初步收益公告和年度报告的叙述方面:研究人员和监管机构的工具和见解
- 批准号:
ES/R003904/1 - 财政年份:2017
- 资助金额:
$ 10.66万 - 项目类别:
Research Grant
The Design of Corporate Annual Reports in London, 1980-2000
1980-2000 年伦敦公司年度报告的设计
- 批准号:
1937453 - 财政年份:2017
- 资助金额:
$ 10.66万 - 项目类别:
Studentship
Making a database of statistical appendices to Annual Reports of the Poor Law Commissioners and those of the Poor Law Board and the analysis of the database.
建立济贫法专员和济贫法委员会年度报告的统计附录数据库,并对数据库进行分析。
- 批准号:
16530240 - 财政年份:2004
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Econological Approach toward Annual Reports
年度报告的经济方法
- 批准号:
07630123 - 财政年份:1995
- 资助金额:
$ 10.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)